Revance Therapeutics Statistics
Total Valuation
HESAY has a market cap or net worth of 257.79 billion. The enterprise value is 248.20 billion.
Market Cap | 257.79B |
Enterprise Value | 248.20B |
Important Dates
The last earnings date was Wednesday, July 30, 2025.
Earnings Date | Jul 30, 2025 |
Ex-Dividend Date | May 6, 2025 |
Share Statistics
Current Share Class | n/a |
Shares Outstanding | n/a |
Shares Change (YoY) | +0.06% |
Shares Change (QoQ) | +0.04% |
Owned by Insiders (%) | n/a |
Owned by Institutions (%) | n/a |
Float | 34.10M |
Valuation Ratios
The trailing PE ratio is 48.99 and the forward PE ratio is 45.08.
PE Ratio | 48.99 |
Forward PE | 45.08 |
PS Ratio | 13.98 |
PB Ratio | 13.21 |
P/TBV Ratio | 13.58 |
P/FCF Ratio | 51.98 |
P/OCF Ratio | 42.01 |
PEG Ratio | n/a |
Enterprise Valuation
The stock's EV/EBITDA ratio is 29.82, with an EV/FCF ratio of 50.05.
EV / Earnings | 47.16 |
EV / Sales | 13.58 |
EV / EBITDA | 29.82 |
EV / EBIT | 32.71 |
EV / FCF | 50.05 |
Financial Position
The company has a current ratio of 4.50, with a Debt / Equity ratio of 0.12.
Current Ratio | 4.50 |
Quick Ratio | 3.39 |
Debt / Equity | 0.12 |
Debt / EBITDA | 0.29 |
Debt / FCF | 0.49 |
Interest Coverage | 104.31 |
Financial Efficiency
Return on equity (ROE) is 28.55% and return on invested capital (ROIC) is 22.49%.
Return on Equity (ROE) | 28.55% |
Return on Assets (ROA) | 19.09% |
Return on Invested Capital (ROIC) | 22.49% |
Return on Capital Employed (ROCE) | 34.70% |
Revenue Per Employee | 717,518 |
Profits Per Employee | 204,790 |
Employee Count | 25,185 |
Asset Turnover | 0.74 |
Inventory Turnover | 1.69 |
Taxes
In the past 12 months, HESAY has paid 2.52 billion in taxes.
Income Tax | 2.52B |
Effective Tax Rate | 32.19% |
Stock Price Statistics
The stock price has increased by +14.79% in the last 52 weeks. The beta is 0.80, so HESAY's price volatility has been lower than the market average.
Beta (5Y) | 0.80 |
52-Week Price Change | +14.79% |
50-Day Moving Average | 269.28 |
200-Day Moving Average | 259.57 |
Relative Strength Index (RSI) | 34.37 |
Average Volume (20 Days) | 41,290 |
Short Selling Information
Short Interest | n/a |
Short Previous Month | n/a |
Short % of Shares Out | n/a |
Short % of Float | n/a |
Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, HESAY had revenue of 18.44 billion and earned 5.26 billion in profits. Earnings per share was 50.12.
Revenue | 18.44B |
Gross Profit | 12.96B |
Operating Income | 7.59B |
Pretax Income | 7.84B |
Net Income | 5.26B |
EBITDA | 7.94B |
EBIT | 7.59B |
Earnings Per Share (EPS) | 50.12 |
Balance Sheet
The company has 12.12 billion in cash and 2.42 billion in debt, giving a net cash position of 9.70 billion.
Cash & Cash Equivalents | 12.12B |
Total Debt | 2.42B |
Net Cash | 9.70B |
Net Cash Per Share | n/a |
Equity (Book Value) | 19.52B |
Book Value Per Share | 185.98 |
Working Capital | 13.13B |
Cash Flow
In the last 12 months, operating cash flow was 6.14 billion and capital expenditures -1.18 billion, giving a free cash flow of 4.96 billion.
Operating Cash Flow | 6.14B |
Capital Expenditures | -1.18B |
Free Cash Flow | 4.96B |
FCF Per Share | n/a |
Margins
Gross margin is 70.31%, with operating and profit margins of 41.19% and 28.54%.
Gross Margin | 70.31% |
Operating Margin | 41.19% |
Pretax Margin | 42.50% |
Profit Margin | 28.54% |
EBITDA Margin | 43.04% |
EBIT Margin | 41.19% |
FCF Margin | 26.90% |
Dividends & Yields
This stock pays an annual dividend of 2.31, which amounts to a dividend yield of 0.94%.
Dividend Per Share | 2.31 |
Dividend Yield | 0.94% |
Dividend Growth (YoY) | 9.06% |
Years of Dividend Growth | 4 |
Payout Ratio | 14.67% |
Buyback Yield | -0.06% |
Shareholder Yield | 0.87% |
Earnings Yield | 2.04% |
FCF Yield | 1.92% |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
Lynch Fair Value | |
Lynch Upside | |
Graham Number | |
Graham Upside |
Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
HESAY has an Altman Z-Score of 30 and a Piotroski F-Score of 7.
Altman Z-Score | 30 |
Piotroski F-Score | 7 |